|
1
|
Rubenfeld GD, Caldwell E, Peabody E,
Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and
outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Butt Y, Kurdowska A and Allen TC: Acute
lung injury: A clinical and molecular review. Arch Pathol Lab Med.
140:345–350. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cheifetz IML: Year in review 2015:
Pediatric ARDS. Respir Care. 61:980–985. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guo Z, Gu Y, Wang C, Zhang J, Shan S, Gu
X, Wang K, Han Y and Ren T: Enforced expression of miR-125b
attenuates LPS-induced acute lung injury. Immunol Lett. 162:18–26.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Luca D, Piastra M, Tosi F, Pulitanò S,
Mancino A, Genovese O, Pietrini D and Conti G: Pharmacological
therapies for pediatric and neonatal ALI/ARDS: An evidence-based
review. Curr Drug Targets. 13:906–916. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chakraborty M, McGreal EP and Kotecha S:
Acute lung injury in preterm newborn infants: Mechanisms and
management. Paediatr Respir Rev. 11:162–170. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fujishima S, Gando S, Daizoh S, Kushimoto
S, Ogura H, Mayumi T, Takuma K, Kotani J, Yamashita N, Tsuruta R,
et al: Infection site is predictive of outcome in acute lung injury
associated with severe sepsis and septic shock. Respirology.
21:898–904. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Quasney MW, López-Fernández YM, Santschi M
and Watson RS; Pediatric Acute Lung Injury Consensus Conference
Group, : The outcomes of children with pediatric acute respiratory
distress syndrome: Proceedings from the pediatric acute lung injury
consensus conference. Pediatr Crit Care Med. 16 (5 Suppl
1):S118–S131. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pediatric Acute Lung Injury Consensus
Conference Group, : Pediatric acute respiratory distress syndrome:
Consensus recommendations from the pediatric acute lung injury
consensus conference. Pediatr Crit Care Med. 16:428–439. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matuschak GM and Lechner AJ: Acute lung
injury and the acute respiratory distress syndrome: Pathophysiology
and treatment. Mo Med. 107:252–258. 2010.PubMed/NCBI
|
|
11
|
Ding Q, Liu GQ, Zeng YY, Zhu JJ, Liu ZY,
Zhang X and Huang JA: Role of IL-17 in LPS-induced acute lung
injury: An in vivo study. Oncotarget. 8:93704–93711.
2017.PubMed/NCBI
|
|
12
|
Wang T, Hou W and Fu Z: Preventative
effect of OMZ-SPT on lipopolysaccharide-induced acute lung injury
and inflammation via nuclear factor-kappa B signaling in mice.
Biochem Biophys Res Commun. 485:284–289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cheng K, Yang A, Hu X, Zhu D and Liu K:
Curcumin attenuates pulmonary inflammation in lipopolysaccharide
induced acute lung injury in neonatal rat model by activating
peroxisome proliferator-activated receptor γ (PPARγ) pathway. Med
Sci Monit. 24:1178–1184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rigouzzo A, Khoy-Ear L, Laude D, Louvet N,
Moutard ML, Sabourdin N and Constant I: EEG profiles during general
anesthesia in children: A comparative study between sevoflurane and
propofol. Paediatr Anaesth. Jan 4–2019.(Epub ahead of print).
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vasileiou I, Xanthos T, Koudouna E, Perrea
D, Klonaris C, Katsargyris A and Papadimitriou L: Propofol: A
review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jiang S, Liu Y, Huang L, Zhang F and Kang
R: Effects of propofol on cancer development and chemotherapy:
Potential mechanisms. Eur J Pharmacol. 831:46–51. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu XR, Cao L, Li T, Chen LL, Yu YY, Huang
WJ, Liu L and Tan XQ: Propofol attenuates
H2O2-induced oxidative stress and apoptosis
via the mitochondria- and ER-medicated pathways in neonatal rat
cardiomyocytes. Apoptosis. 22:639–646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kaur J, Flores Gutiérrez J and Nistri A:
Neuroprotective effect of propofol against excitotoxic injury to
locomotor networks of the rat spinal cord in vitro. Eur J Neurosci.
44:2418–2430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zheng X, Huang H, Liu J, Li M, Liu M and
Luo T: Propofol attenuates inflammatory response in LPS-activated
microglia by regulating the miR-155/SOCS1 pathway. Inflammation.
41:11–19. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu S, Sun JY, Ren LP, Chen K and Xu B:
Propofol attenuates intermittent hypoxia induced up-regulation of
proinflammatory cytokines in microglia through inhibiting the
activation of NF-Bκ/p38 MAPK signalling. Folia Neuropathol.
55:124–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yuan D, Su G, Liu Y, Chi X, Feng J, Zhu Q,
Cai J, Luo G and Hei Z: Propofol attenuated liver
transplantation-induced acute lung injury via connexin43 gap
junction inhibition. J Transl Med. 14:1942016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu W, Zhu H and Fang H: Propofol
potentiates sevoflurane-induced inhibition of nuclear
factor-κB-mediated inflammatory responses and regulation of
mitogen-activated protein kinases pathways via toll-like receptor 4
signaling in lipopolysaccharide-induced acute lung injury in mice.
Am J Med Sci. 354:493–505. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tan Z, Wang H, Sun J and Li M: Effects of
propofol pretreatment on lung morphology and heme oxygenase-1
expression in oleic acid-induced acute lung injury in rats. Acta
Cir Bras. 33:250–258. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma J, Xiao W, Wang J, Wu J, Ren J, Hou J,
Gu J, Fan K and Yu B: Propofol inhibits NLRP3 inflammasome and
attenuates blast-induced traumatic brain injury in rats.
Inflammation. 39:2094–2103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lv H, Zhu C, Liao Y, Gao Y, Lu G, Zhong W,
Zheng Y, Chen W and Ci X: Tenuigenin ameliorates acute lung injury
by inhibiting NF-κB and MAPK signalling pathways. Respir Physiol
Neurobiol. 216:43–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu X, Shen H, Wang Y and Zhao M: Liver X
receptor agonist TO901317 attenuates paraquat-induced acute lung
injury through inhibition of NF-κB and JNK/p38 MAPK signal
pathways. Biomed Res Int. 2017:46526952017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grailer JJ, Canning BA, Kalbitz M,
Haggadone MD, Dhond RM, Andjelkovic AV, Zetoune FS and Ward PA:
Critical role for the NLRP3 inflammasome during acute lung injury.
J Immunol. 192:5974–5983. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang S, Zhao J, Wang H, Liang Y, Yang N
and Huang Y: Blockage of P2X7 attenuates acute lung injury in mice
by inhibiting NLRP3 inflammasome. Int Immunopharmacol. 27:38–45.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bayne K: Revised guide for the care and
use of laboratory animals available. American physiological
society. Physiologist. 39:199–208, 211. 1996.PubMed/NCBI
|
|
30
|
Wang X, Liu C and Wang G: Propofol
protects rats and human alveolar epithelial cells against
lipopolysaccharide-induced acute lung injury via inhibiting HMGB1
expression. Inflammation. 39:1004–1016. 2016.PubMed/NCBI
|
|
31
|
Wang C, Zeng L, Zhang T, Liu J and Wang W:
Casticin inhibits lipopolysaccharide-induced acute lung injury in
mice. Eur J Pharmacol. 789:172–178. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gando S, Kameue T, Matsuda N, Sawamura A,
Hayakawa M and Kato H: Systemic inflammation and disseminated
intravascular coagulation in early stage of ALI and ARDS: role of
neutrophil and endothelial activation. Inflammation. 28:237–244.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Azevedo ZM, Moore DB, Lima FC, Cardoso CC,
Bougleux R, Matos GI, Luz RA, Xavier-Elsas P, Sampaio EP,
Gaspar-Elsas MI and Moraes MO: Tumor necrosis factor (TNF) and
lymphotoxin-alpha (LTA) single nucleotide polymorphisms: Importance
in ARDS in septic pediatric critically ill patients. Hum Immunol.
73:661–667. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rabelo MAE, Lucinda LMF, Reboredo MM, da
Fonseca LMC, Reis FF, Fazza TF, Brega DR, de Paoli F, de Souza da
Fonseca A and Pinheiro BV: Acute lung injury in response to
intratracheal instillation of lipopolysaccharide in an animal model
of emphysema induced by elastase. Inflammation. 41:174–182. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen C, Shi L, Li Y, Wang X and Yang S:
Disease-specific dynamic biomarkers selected by integrating
inflammatory mediators with clinical informatics in ARDS patients
with severe pneumonia. Cell Biol Toxicol. 32:169–184. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Abderrazak A, Syrovets T, Couchie D, El
Hadri K, Friguet B, Simmet T and Rouis M: NLRP3 inflammasome: From
a danger signal sensor to a regulatory node of oxidative stress and
inflammatory diseases. Redox Biol. 4:296–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Franco ML, Waszak P, Banalec G, Levame M,
Lafuma C, Harf A and Delacourt C: LPS-induced lung injury in
neonatal rats: Changes in gelatinase activities and consequences on
lung growth. Am J Physiol Lung Cell Mol Physiol. 282:L491–L500.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Miotla JM, Teixeira MM and Hellewell PG:
Suppression of acute lung injury in mice by an inhibitor of
phosphodiesterase type 4. Am J Respir Cell Mol Biol. 18:411–420.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shi D, Zheng M, Wang Y, Liu C and Chen S:
Protective effects and mechanisms of mogroside V on LPS-induced
acute lung injury in mice. Pharm Biol. 52:729–734. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun A, Wang W, Ye X, Wang Y, Yang X, Ye Z,
Sun X and Zhang C: Protective effects of methane-rich saline on
rats with lipopolysaccharide-induced acute lung injury. Oxid Med
Cell Longev. 2017:74301932017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang J, Li R, Peng Z, Zhou W, Hu B, Rao X,
Yang X and Li J: GTS-21 reduces inflammation in acute lung injury
by regulating M1 polarization and function of alveolar macrophages.
Shock. 30–Mar;2018.(Epub ahead of print).
|
|
43
|
Gao S, Li H, Zhou XQ, You JB, Tu DN, Xia
G, Jiang JX and Xin C: Withaferin A attenuates
lipopolysaccharide-induced acute lung injury in neonatal rats. Cell
Mol Biol (Noisy-le-grand). 61:102–106. 2015.PubMed/NCBI
|
|
44
|
Hua S, Liu X, Lv S and Wang Z: Protective
effects of cucurbitacin B on acute lung injury induced by sepsis in
rats. Med Sci Monit. 23:1355–1362. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Dong Z and Yuan Y: Accelerated
inflammation and oxidative stress induced by LPS in acute lung
injury: Inhibition by ST1926. Int J Mol Med. 41:3405–3421.
2018.PubMed/NCBI
|
|
46
|
Du L, Hu X, Chen C, Kuang T, Yin H and Wan
L: Seabuckthorn paste protects lipopolysaccharide-induced acute
lung injury in mice through attenuation of oxidative stress. Oxid
Med Cell Longev. 2017:41309672017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Park HJ, Shin JY, Kim MH and Park BJ:
Increased use in propofol and reported patterns of adverse events
among anesthetics in Korea. Regul Toxicol Pharmacol. 71:478–483.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bonnet U and Scherbaum N: Craving
dominates propofol addiction of an affected physician. J
Psychoactive Drugs. 44:186–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bonnet U: Assessment of the addictive risk
of propofol. Fortschr Neurol Psychiatr. 79:442–452. 2011.(In
German). View Article : Google Scholar : PubMed/NCBI
|
